pembrolizumab
merck
['melsm', 'melanoma', 'pembro']
swog s1801: neoadjuvant and adjuvant pembrolizumab for patients with stage iiib to iv melanoma #melsm #skcsm #immunotherapy #oncology #esmo22
News and views from the world of clinical oncology and hematology